AdvanSource Biomaterials said today it tapped Boston-based investment bank Mirus Securities to help provide guidance to the company.
Wilmington, Mass.-based Advansource Biomaterials manufactures polymer materials used for the design and development of medical devices, specifically those designed to treat anatomical sites and disease states.
The investment firm, which has in-depth experience with med-tech manufacturing, has been brought on to provide general guidance and assess “strategic alternatives,” according to a press release.
Mirus offers investment banking solutions to businesses in health care, technology, business services, manufacturing and other businesses, and provides corporate finance advisory service on mergers, acquisitions, divestures, recapitalizations and valuations.
The post AdvanSource taps Mirus for ‘strategic alternatives’ appeared first on MassDevice.
from MassDevice http://ift.tt/1QXctjT
Cap comentari:
Publica un comentari a l'entrada